The Diagnostic Path: IASP Criteria
At a Glance
Nociplastic pain is diagnosed clinically, not by a definitive scan or blood test. The 2021 IASP criteria look for at least three months of regional or widespread pain, hypersensitivity, and no sole tissue or nerve cause; probable cases add a history of sensitivity and at least one related symptom.
Because nociplastic pain involves a change in how the nervous system processes signals rather than a visible injury, it cannot be “seen” on a standard scan or measured in a blood test. There is no unique biomarker—like a high blood sugar level for diabetes—that definitively proves you have it [1][2]. Instead, doctors use clinical evaluation to determine if your pain fits this mechanism [3].
The Two Levels of Diagnosis
To help standardize this, the International Association for the Study of Pain (IASP) published a proposed clinical grading framework in 2021, primarily intended for chronic musculoskeletal pain. It is a clinical aid, not a definitive disease diagnosis, and categorizes your pain as either “possible” or “probable” nociplastic pain.
1. Possible Nociplastic Pain
To meet this first level, you must fulfill all four of these requirements:
- Duration: Your pain has lasted for at least 3 months [3].
- Distribution: Your pain is regional, multifocal (in several separate spots), or widespread [3]. It is not limited to one tiny, discrete point.
- Unexplained by Other Types: Your pain cannot be entirely explained by tissue damage (nociceptive) or a specific nerve injury (neuropathic)—though nociplastic and structural mechanisms frequently coexist [3].
- Clinical Hypersensitivity: During a physical exam, your doctor finds signs that you are extra sensitive to pressure, touch, or movement in the area where you feel pain [3].
2. Probable Nociplastic Pain
To move from “possible” to “probable,” you must meet the criteria above plus two additional factors:
- History of Sensitivity: You report a history of pain from things that shouldn’t hurt (like a light touch) or an exaggerated response to things that are only mildly painful [4].
- Associated Comorbidities: You experience at least one of the “neighboring” symptoms we discussed earlier, such as extreme fatigue, unrefreshing sleep, “brain fog,” or sensitivity to light, sound, or odors [4].
Quantitative Sensory Testing (QST)
While there is no blood test, some specialists use Quantitative Sensory Testing (QST) to help identify nociplastic pain. QST is a standardized way to measure how your nervous system responds to physical stimuli like pressure, heat, or cold [5].
- Pressure Thresholds: Measuring how much pressure it takes before you feel pain [5].
- Temporal Summation: Checking if repeated, mild stimuli (like a small tap) feel increasingly painful over time [6].
- Conditioned Pain Modulation: Testing your body’s natural “pain-filtering” system to see if it is working properly [6].
While QST can provide a “profile” of your sensitivity, it is not routinely necessary and is not a standalone diagnostic test. It is one tool used alongside your history and physical exam [7][8].
Evaluating Your Diagnosis
Nociplastic pain often involves a selective, clinician-directed evaluation to ensure other treatable conditions are identified. You can ensure your diagnosis is thorough by discussing two things:
- A Focused Neurologic Exam: Did your doctor check your reflexes, muscle strength, and specific sensation patterns? This helps assess for large-fiber neuropathic pain. However, note that a neurologic examination cannot by itself rule out all neuropathic pain; small-fiber disorders may have limited routine examination findings [9][10].
- Contextual Imaging: If you had an MRI or X-ray that showed an “abnormality” (like a bulging disc), did your doctor confirm that it actually matches your pain? Most healthy adults have some spinal anomalies on imaging that cause no pain at all [11]. If your pain is widespread, a focal MRI finding does not rule out nociplastic pain; rather, nociplastic and structural mechanisms may coexist [11][10].
If your records don’t show that your doctor looked for these specific patterns, it is a great time to ask for a more detailed assessment [12].
Common questions in this guide
How is nociplastic pain diagnosed if tests look normal?
What makes nociplastic pain possible rather than probable?
What does quantitative sensory testing show?
Can an MRI abnormality rule out nociplastic pain?
Why might I need a focused neurologic examination?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the 2021 IASP criteria, is my pain currently classified as 'possible' or 'probable' nociplastic pain?
- 2.What specific signs of hypersensitivity did you find during my physical exam?
- 3.How did you evaluate for 'nociceptive' causes like hidden inflammation or 'neuropathic' causes like a pinched nerve?
- 4.Which parts of my medical history or symptoms most strongly support a nociplastic mechanism over other types?
- 5.If we haven't done a focused neurologic exam—checking my reflexes, strength, and specific sensation patterns—should we do one to assess for nerve issues?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future.
Nijs J, Lahousse A, Kapreli E, et al.
Journal of clinical medicine 2021; (10(15)) doi:10.3390/jcm10153203.
PMID: 34361986 - 2
Nociplastic Pain: Facts, Controversies and Future Tasks.
Häuser W, Kosek E
European journal of pain (London, England) 2026; (30(1)):e70175 doi:10.1002/ejp.70175.
PMID: 41294344 - 3
The concept of nociplastic pain-where to from here?
Kosek E
Pain 2024; (165(11S)):S50-S57 doi:10.1097/j.pain.0000000000003305.
PMID: 39560415 - 4
Current understanding of nociplastic pain.
Yoo YM, Kim KH
The Korean journal of pain 2024; (37(2)):107-118 doi:10.3344/kjp.23326.
PMID: 38504389 - 5
Quantitative Sensory Testing - From bench to bedside.
Hughes S, Vollert J, Freeman R, Forstenpointner J
International review of neurobiology 2024; (179()):67-90 doi:10.1016/bs.irn.2024.10.011.
PMID: 39580222 - 6
Quantitative Sensory Testing in pain assesment and treatment. Brief review and algorithmic management proposal.
Avellanal M, Riquelme I, Díaz-Regañón G
Revista espanola de anestesiologia y reanimacion 2020; (67(4)):187-194 doi:10.1016/j.redar.2020.01.006.
PMID: 32113579 - 7
Is the Central Sensitization Inventory (CSI) associated with quantitative sensory testing (QST)? A systematic review and meta-analysis.
Neblett R, Sanabria-Mazo JP, Luciano JV, et al.
Neuroscience and biobehavioral reviews 2024; (161()):105612 doi:10.1016/j.neubiorev.2024.105612.
PMID: 38604015 - 8
Quantitative sensory testing and exercise-induced hypoalgesia protocols in low back pain: A scoping review.
Goodman LR, Dass R, Daniel E, et al.
The journal of pain 2025; (28()):104725 doi:10.1016/j.jpain.2024.104725.
PMID: 39532209 - 9
Neuropathic Pain: From Mechanisms to Treatment.
Finnerup NB, Kuner R, Jensen TS
Physiological reviews 2021; (101(1)):259-301 doi:10.1152/physrev.00045.2019.
PMID: 32584191 - 10
Neuropathic pain: principles of diagnosis and treatment.
Gilron I, Baron R, Jensen T
Mayo Clinic proceedings 2015; (90(4)):532-45.
PMID: 25841257 - 11
Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: a systematic review.
Shraim MA, Massé-Alarie H, Hodges PW
Pain 2021; (162(4)):1007-1037 doi:10.1097/j.pain.0000000000002113.
PMID: 33136983 - 12
Pain assessment 3 × 3: a clinical reasoning framework for healthcare professionals.
Bäckryd E
Scandinavian journal of pain 2023; (23(2)):268-272 doi:10.1515/sjpain-2023-0007.
PMID: 36869594
This page explains the clinical assessment of nociplastic pain for informational purposes only and does not constitute medical advice. Your clinician should interpret your examination, imaging, and any QST results in the context of your symptoms.
Get notified when new evidence is published on Nociplastic Pain.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.